spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  adipose-derived 

 HSMN NewsFeed - 16 Feb 2021
Akan Biosciences Announces FDA Acceptance of IND Application for StroMel(TM) in Osteoarthritis of Knee
Regenerative Medicine Orthopaedic FDA
 HSMN NewsFeed - 12 Dec 2018
NOVADIP BIOSCIENCES Appoints Jeff Abbey as CEO
Regenerative Medicine Personnel
 HSMN NewsFeed - 24 Apr 2017
Millennium Medical Technologies (MMT) First in the Nation to Receive FDA Clearance for a Reusable Fat Collection and Grafting System
Devices Surgery FDA
 HSMN NewsFeed - 23 Sep 2016
Biologica Technologies(R) launches Allofill(TM) injectable adipose filler at the annual gathering for the American Society of Plastic Surgeons (ASPS)
Devices Dermatology Product Launch
 HSMN NewsFeed - 5 Jul 2016
Takeda and TiGenix Enter into Licensing Agreement for Ex-U.S. Rights to Cx601 for the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease
Biopharmaceuticals Regenerative Medicine Licensing
 HSMN NewsFeed - 4 Aug 2015
Healeon Medical Names Dr. Robert Alexander as Chief Scientific Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 4 Nov 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia(TM) in Europe
Regenerative Medicine HIV/AIDS
 HSMN NewsFeed - 26 Feb 2013
Cytori Appoints Dr. Steven Kesten as Executive Vice President and Chief Medical Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 25 Feb 2013
Intravase(R) Approval Opens Vascular Market for Cytori
Regenerative Medicine FDA
 HSMN NewsFeed - 14 Nov 2012
StemGenex(TM) on the Forefront of Adult Stem Cell-Based Therapy for Alzheimer's
Regenerative Medicine Neurology
 HSMN NewsFeed - 11 Oct 2012
First Patient Treated in Cytori’s U.S. Cell Therapy Heart Failure Trial
Regenerative Medicine Cardiology
 HSMN NewsFeed - 16 Mar 2012
FDA Grants Cytori 510(k) Clearance for Puregraft(R) 850
Devices FDA
 HSMN NewsFeed - 14 Feb 2012
Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute's Adipose Cell Technology
Regenerative Medicine Cardiology
 HSMN NewsFeed - 30 Jan 2012
Cytori Receives Approval From FDA to Initiate U.S. Cardiac Cell Therapy Trial; Investigational Device Exemption (IDE) Approved for ATHENA
Regenerative Medicine Cardiology
 HSMN NewsFeed - 24 Jan 2012
Adipose Stem Cell Heart Attack Trial Data Published in Journal of the American College of Cardiology; Cytori's APOLLO Trial Demonstrated Safety & Feasibility and Improvements in Cardiac Function
Regenerative Medicine Cardiology
 HSMN NewsFeed - 27 Jul 2010
Cytori Gains Stem Cell Device Approval in Europe for Breast Cancer Reconstruction and Soft Tissue Repair
Devices Regenerative Medicine Regulatory
 HSMN NewsFeed - 17 Jun 2010
Breast Cancer Reconstruction Using Cell-Enriched Fat Grafts Shows Continued High Rates of Physician and Patient Satisfaction at 12 Months
Regenerative Medicine Oncology
 HSMN NewsFeed - 1 May 2008
Cytori Begins Breast Reconstruction Study in Europe
Regenerative Medicine
 HSMN NewsFeed - 22 Feb 2008
Cell-Enhanced Breast Reconstruction Study Shows Sustained Improvement at 12-Months
Regenerative Medicine
 HSMN NewsFeed - 30 Jan 2008
First Patients Treated in Cytori's Stem & Regenerative Cell Heart Attack Study
Regenerative Medicine Cardiology
 HSMN NewsFeed - 17 Dec 2007
Adipose-Derived Stem Cells Show Promise in Breast Reconstruction
Regenerative Medicine Oncology
 HSMN NewsFeed - 6 Nov 2007
Cytori's Celution(TM) System Under Evaluation for Breast Augmentation as Part of Investigator-Initiated Study
Regenerative Medicine
 HSMN NewsFeed - 1 Nov 2007
Cytori Receives European Approval for 2nd Generation Celution(TM) Stem & Regenerative Cell Processing System
Devices Regenerative Medicine Regulatory
 HSMN NewsFeed - 1 Oct 2007
Axcan Licenses Rights to Cx401, an Innovative Biological Product in Development for the Treatment of Perianal Fistulas, a Significant Unmet Medical Need
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 1 Jun 2007
Cytori Divests HYDROSORB(TM) Surgical Implant Product Line to Kensey Nash for $3.2 Million
Devices Orthopaedic Neurosurgery Acquisitions
 HSMN NewsFeed - 5 Feb 2007
First Heart Patient Treated in Adipose Stem Cell Trial; Cytori's Cardiovascular Stem Cell Study Initiated
Regenerative Medicine Cardiology
 HSMN NewsFeed - 17 Jan 2007
Dr. Jorge Genovese Joins Bioheart, Inc. Scientific Advisory Board
Regenerative Medicine Cardiology Personnel
 HSMN NewsFeed - 3 Jan 2007
Cytori to Begin Stem Cell Trial for Heart Disease
Regenerative Medicine Cardiology
 HSMN NewsFeed - 14 Nov 2006
Enrollment Completed Utilizing Cytori's Adipose-Derived Stem Cell Technology for Treatment of Breast Cancer Complications
Regenerative Medicine Oncology
 HSMN NewsFeed - 1 Jun 2006
First Three Patients Treated in Adipose Stem and Regenerative Cell Clinical Safety and Feasibility Study for Breast Reconstruction
Regenerative Medicine
Return to NewsFeed  

 Additional items found! 6

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 6 additional stories matching:
adipose-derived
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!